Triathlon Medical Venture Partners
37
17M
15
1.95
7
0.59
10
- Stages of investment
- Areas of investment
Summary
In 2004 was created Triathlon Medical Venture Partners, which is appeared as VC. The venture was found in North America in United States. The main department of described VC is located in the Cincinnati.
The real fund results show that this VC is 5 percentage points less often commits exit comparing to other companies. The fund is constantly included in 2-6 deals per year. The top amount of exits for fund were in 2015. Opposing the other organizations, this Triathlon Medical Venture Partners works on 11 percentage points less the average amount of lead investments. The common things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2008.
We can highlight the next thriving fund investment areas, such as Pharmaceutical, Therapeutics. The fund has exact preference in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular portfolio startups of the fund, we may highlight Mitralign, BioVex, Juventas Therapeutics.
The fund was created by Dennis B. Costello, John M. Rice. We also calculated 4 valuable employees in our database.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Triathlon Medical Venture Partners, startups are often financed by Oxford Bioscience Partners, Venture Investors, Sanderling Ventures. The meaningful sponsors for the fund in investment in the same round are Venture Investors, Oxford Bioscience Partners, Kearny Venture Partners. In the next rounds fund is usually obtained by Venture Investors, Oxford Bioscience Partners, Athenian Venture Partners.
Investments analytics
Analytics
- Total investments
- 37
- Lead investments
- 7
- Exits
- 10
- Rounds per year
- 1.95
- Follow on index
- 0.59
- Investments by industry
- Health Care (27)
- Biotechnology (24)
- Medical (18)
- Medical Device (17)
- Therapeutics (16) Show 13 more
- Investments by region
-
- United States (34)
- United Kingdom (2)
- Israel (1)
- Peak activity year
- 2008
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 19
- Avg. valuation at time of investment
- 146M
- Group Appearance index
- 0.89
- Avg. company exit year
- 14
- Avg. multiplicator
- 2.03
- Strategy success index
- 0.80
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Akebia Therapeutics | 28 Jul 2009 | Biotechnology, Health Care, Therapeutics | Early Stage Venture | 25M | United States, Cambridge, Massachusetts |
| Renal Solutions | 08 Mar 2005 | Health Care, Medical Device, Medical | Early Stage Venture | 16M | United States, Pennsylvania |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.